PMC:7212949 / 52891-53720 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T291","span":{"begin":347,"end":350},"obj":"Body_part"},{"id":"T292","span":{"begin":816,"end":820},"obj":"Body_part"}],"attributes":[{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma59756"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T408","span":{"begin":160,"end":170},"obj":"Disease"},{"id":"T409","span":{"begin":211,"end":217},"obj":"Disease"},{"id":"T410","span":{"begin":380,"end":404},"obj":"Disease"},{"id":"T411","span":{"begin":420,"end":432},"obj":"Disease"},{"id":"T412","span":{"begin":451,"end":459},"obj":"Disease"},{"id":"T413","span":{"begin":467,"end":475},"obj":"Disease"},{"id":"T414","span":{"begin":496,"end":504},"obj":"Disease"},{"id":"T415","span":{"begin":509,"end":519},"obj":"Disease"},{"id":"T416","span":{"begin":562,"end":586},"obj":"Disease"},{"id":"T419","span":{"begin":603,"end":647},"obj":"Disease"}],"attributes":[{"id":"A408","pred":"mondo_id","subj":"T408","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A409","pred":"mondo_id","subj":"T409","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"},{"id":"A410","pred":"mondo_id","subj":"T410","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A411","pred":"mondo_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A412","pred":"mondo_id","subj":"T412","obj":"http://purl.obolibrary.org/obo/MONDO_0005336"},{"id":"A413","pred":"mondo_id","subj":"T413","obj":"http://purl.obolibrary.org/obo/MONDO_0005336"},{"id":"A414","pred":"mondo_id","subj":"T414","obj":"http://purl.obolibrary.org/obo/MONDO_0005336"},{"id":"A415","pred":"mondo_id","subj":"T415","obj":"http://purl.obolibrary.org/obo/MONDO_0005244"},{"id":"A416","pred":"mondo_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A417","pred":"mondo_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A418","pred":"mondo_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/MONDO_0020671"},{"id":"A419","pred":"mondo_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/MONDO_0001243"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T540","span":{"begin":228,"end":231},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T541","span":{"begin":241,"end":242},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T542","span":{"begin":520,"end":523},"obj":"http://purl.obolibrary.org/obo/CLO_0053001"},{"id":"T543","span":{"begin":552,"end":553},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T544","span":{"begin":807,"end":812},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19221","span":{"begin":479,"end":484},"obj":"Chemical"},{"id":"T25","span":{"begin":643,"end":646},"obj":"Chemical"}],"attributes":[{"id":"A56836","pred":"chebi_id","subj":"T19221","obj":"http://purl.obolibrary.org/obo/CHEBI_27026"},{"id":"A62008","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_4305"},{"id":"A64261","pred":"chebi_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/CHEBI_53092"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T69","span":{"begin":630,"end":641},"obj":"http://purl.obolibrary.org/obo/GO_0050817"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T287","span":{"begin":53,"end":79},"obj":"Phenotype"},{"id":"T288","span":{"begin":160,"end":170},"obj":"Phenotype"},{"id":"T289","span":{"begin":211,"end":217},"obj":"Phenotype"},{"id":"T290","span":{"begin":420,"end":432},"obj":"Phenotype"},{"id":"T291","span":{"begin":451,"end":459},"obj":"Phenotype"},{"id":"T292","span":{"begin":467,"end":475},"obj":"Phenotype"},{"id":"T293","span":{"begin":496,"end":504},"obj":"Phenotype"},{"id":"T294","span":{"begin":509,"end":519},"obj":"Phenotype"},{"id":"T295","span":{"begin":562,"end":586},"obj":"Phenotype"},{"id":"T296","span":{"begin":603,"end":641},"obj":"Phenotype"},{"id":"T297","span":{"begin":643,"end":646},"obj":"Phenotype"}],"attributes":[{"id":"A287","pred":"hp_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/HP_0000707"},{"id":"A288","pred":"hp_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A289","pred":"hp_id","subj":"T289","obj":"http://purl.obolibrary.org/obo/HP_0001251"},{"id":"A290","pred":"hp_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/HP_0002383"},{"id":"A291","pred":"hp_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/HP_0003198"},{"id":"A292","pred":"hp_id","subj":"T292","obj":"http://purl.obolibrary.org/obo/HP_0003198"},{"id":"A293","pred":"hp_id","subj":"T293","obj":"http://purl.obolibrary.org/obo/HP_0003198"},{"id":"A294","pred":"hp_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/HP_0009830"},{"id":"A295","pred":"hp_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A296","pred":"hp_id","subj":"T296","obj":"http://purl.obolibrary.org/obo/HP_0005521"},{"id":"A297","pred":"hp_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/HP_0005521"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-sentences","denotations":[{"id":"T537","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T538","span":{"begin":9,"end":80},"obj":"Sentence"},{"id":"T539","span":{"begin":81,"end":829},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1317","span":{"begin":121,"end":125},"obj":"UBERON:0000033"},{"id":"T1318","span":{"begin":173,"end":179},"obj":"UBERON:2000280"},{"id":"T1319","span":{"begin":180,"end":187},"obj":"UBERON:0001897"},{"id":"T1320","span":{"begin":228,"end":233},"obj":"UBERON:0000955"},{"id":"T1321","span":{"begin":290,"end":297},"obj":"UBERON:0001897"},{"id":"T1322","span":{"begin":299,"end":305},"obj":"UBERON:0011306"},{"id":"T1323","span":{"begin":306,"end":320},"obj":"UBERON:0001871"},{"id":"T1324","span":{"begin":386,"end":400},"obj":"UBERON:0000391"},{"id":"T1325","span":{"begin":493,"end":496},"obj":"GO:0071735"},{"id":"T1326","span":{"begin":619,"end":625},"obj":"UBERON:0004288"},{"id":"T1327","span":{"begin":716,"end":719},"obj":"UBERON:0001017"},{"id":"T1328","span":{"begin":756,"end":766},"obj":"CL:0000542"},{"id":"T1329","span":{"begin":771,"end":779},"obj":"CL:0000233"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1291","span":{"begin":9,"end":17},"obj":"Species"},{"id":"1292","span":{"begin":254,"end":262},"obj":"Species"},{"id":"1293","span":{"begin":314,"end":322},"obj":"Species"},{"id":"1294","span":{"begin":361,"end":369},"obj":"Species"},{"id":"1295","span":{"begin":768,"end":776},"obj":"Species"},{"id":"1296","span":{"begin":53,"end":79},"obj":"Disease"},{"id":"1297","span":{"begin":147,"end":170},"obj":"Disease"},{"id":"1298","span":{"begin":191,"end":206},"obj":"Disease"},{"id":"1299","span":{"begin":211,"end":217},"obj":"Disease"},{"id":"1300","span":{"begin":268,"end":289},"obj":"Disease"},{"id":"1301","span":{"begin":420,"end":432},"obj":"Disease"},{"id":"1302","span":{"begin":434,"end":459},"obj":"Disease"},{"id":"1303","span":{"begin":461,"end":475},"obj":"Disease"},{"id":"1304","span":{"begin":496,"end":519},"obj":"Disease"},{"id":"1305","span":{"begin":562,"end":586},"obj":"Disease"},{"id":"1306","span":{"begin":603,"end":641},"obj":"Disease"},{"id":"1307","span":{"begin":643,"end":646},"obj":"Disease"}],"attributes":[{"id":"A1291","pred":"tao:has_database_id","subj":"1291","obj":"Tax:1335626"},{"id":"A1292","pred":"tao:has_database_id","subj":"1292","obj":"Tax:9606"},{"id":"A1293","pred":"tao:has_database_id","subj":"1293","obj":"Tax:1335626"},{"id":"A1294","pred":"tao:has_database_id","subj":"1294","obj":"Tax:9606"},{"id":"A1295","pred":"tao:has_database_id","subj":"1295","obj":"Tax:1335626"},{"id":"A1296","pred":"tao:has_database_id","subj":"1296","obj":"MESH:D009422"},{"id":"A1297","pred":"tao:has_database_id","subj":"1297","obj":"MESH:D018908"},{"id":"A1298","pred":"tao:has_database_id","subj":"1298","obj":"MESH:D006970"},{"id":"A1299","pred":"tao:has_database_id","subj":"1299","obj":"MESH:D001259"},{"id":"A1300","pred":"tao:has_database_id","subj":"1300","obj":"MESH:D009422"},{"id":"A1301","pred":"tao:has_database_id","subj":"1301","obj":"MESH:D004660"},{"id":"A1302","pred":"tao:has_database_id","subj":"1302","obj":"MESH:D016638"},{"id":"A1304","pred":"tao:has_database_id","subj":"1304","obj":"MESH:D009135"},{"id":"A1305","pred":"tao:has_database_id","subj":"1305","obj":"MESH:D020521"},{"id":"A1306","pred":"tao:has_database_id","subj":"1306","obj":"MESH:D004211"},{"id":"A1307","pred":"tao:has_database_id","subj":"1307","obj":"MESH:D004211"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}

{"project":"2_test","denotations":[{"id":"32620220-28748673-2074194","span":{"begin":228,"end":231},"obj":"28748673"},{"id":"32620220-28748673-2074195","span":{"begin":520,"end":523},"obj":"28748673"}],"text":"MERS-CoV\nMERS-CoV causes both central and peripheral neurological abnormalities. Neurological symptoms occur later in the course of the illness as weakness and neuropathy and less frequently hypersomnolence and ataxia (Table 5).114 , 115 In a study of 4 patients with neurological symptoms conducted by Kim et al, MERS-CoV was not detected in the CSF, however, patients developed Guillain-Barre’ syndrome, Bickerstaff's encephalitis, critical illness myopathy, viral myopathy or toxin associated myopathy and neuropathy.114 Algahtani et al also report a case of cerebrovascular accident attributable to disseminated intravascular coagulation (DIC) and viral-induced autoimmune response.115 The authors are not aware of evidence describing the ocular manifestations of MERS-CoV or the ability to isolate the virus in tear samples."}